Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
AstraZeneca
AstraZeneca
Yonsei University
Amager Hospital
University Health Network, Toronto
University Hospital, Caen
Virginia Commonwealth University
Brigham and Women's Hospital
National Institute of Cardiology, Warsaw, Poland
Washington University School of Medicine
Skribe Medical
Karolinska Institutet
Duke University
University Hospital Muenster
Mayo Clinic
NHS Greater Glasgow and Clyde
Brigham and Women's Hospital